Paper36094643
Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
Diao J and 4 others. Invest Ophthalmol Vis Sci, 2022. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts. Papers, record 36094643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36094643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Berberine | Major topic |
| Graves Ophthalmopathy | Major topic |
| Fibroblasts | |
| Fibrosis | |
| Humans | |
| Hyaluronic Acid | |
| Inflammation | |
| Orbit | |
| Transforming Growth Factor beta |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26287404 | Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts. | Endocrinology | 2015 | https://conductscience.org/library/papers/26287404 | PubMed |
| 2 | 30551199 | The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy. | Invest Ophthalmol Vis Sci | 2018 | https://conductscience.org/library/papers/30551199 | PubMed |
| 3 | 26119076 | Anti-adipogenic effect of epiberberine is mediated by regulation of the Raf/MEK1/2/ERK1/2 and AMPKα/Akt pathways. | Arch Pharm Res | 2015 | https://conductscience.org/library/papers/26119076 | PubMed |
| 4 | 32908802 | Integrating Differential Gene Expression Analysis with Perturbagen-Response Signatures May Identify Novel Therapies for Thyroid-Associated Orbitopathy. | Transl Vis Sci Technol | 2020 | https://conductscience.org/library/papers/32908802 | PubMed |
| 5 | 10209157 | Multiple signals converging on NF-kappaB. | Curr Opin Cell Biol | 1999 | https://conductscience.org/library/papers/10209157 | PubMed |
| 6 | 22632361 | Evaluating Graves' orbitopathy. | Best Pract Res Clin Endocrinol Metab | 2012 | https://conductscience.org/library/papers/22632361 | PubMed |
| 7 | 35082799 | The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome. | Front Immunol | 2021 | https://conductscience.org/library/papers/35082799 | PubMed |
| 8 | 35308208 | Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35308208 | PubMed |
| 9 | 34605662 | Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an In Vitro Model of Graves' Orbitopathy. | Thyroid | 2022 | https://conductscience.org/library/papers/34605662 | PubMed |
| 10 | 30081019 | Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial. | Am J Ophthalmol | 2018 | https://conductscience.org/library/papers/30081019 | PubMed |
| 11 | 26722438 | Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26722438 | PubMed |
| 12 | 26851175 | Research progress on berberine with a special focus on its oral bioavailability. | Fitoterapia | 2016 | https://conductscience.org/library/papers/26851175 | PubMed |
| 13 | 19633293 | Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19633293 | PubMed |
| 14 | 21239515 | Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity. | J Clin Endocrinol Metab | 2011 | https://conductscience.org/library/papers/21239515 | PubMed |
| 15 | 27797318 | Graves' Disease. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27797318 | PubMed |
| 16 | 24093679 | AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. | Cell Metab | 2013 | https://conductscience.org/library/papers/24093679 | PubMed |
| 17 | 31952433 | Development of a Novel Anti-Obesity Compound with Inhibiting Properties on the Lipid Accumulation in 3T3-L1 Adipocytes | Iran Biomed J | 2020 | https://conductscience.org/library/papers/31952433 | PubMed |
| 18 | 34263138 | Updates on the understanding and management of thyroid eye disease. | Ther Adv Ophthalmol | 2021 | https://conductscience.org/library/papers/34263138 | PubMed |
| 19 | 19251722 | Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. | Cardiovasc Res | 2009 | https://conductscience.org/library/papers/19251722 | PubMed |
| 20 | 18788919 | Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. | Thyroid | 2008 | https://conductscience.org/library/papers/18788919 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42377770 | Berberine in breast cancer, a multi-targeted therapeutic agent from mechanisms to clinical translation. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42377770 | PubMed |
| 41375198 | Ocular Toxicity and Mechanistic Investigation for Berberine and Its Metabolite Berberrubine on Zebrafish. | Molecules | 2025 | https://conductscience.org/library/papers/41375198 | PubMed |
| 40771890 | Cerium oxide nanoparticles attenuates fibrosis and inflammation in thyroid-associated ophthalmopathy via JNK pathway. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/40771890 | PubMed |
| 40734440 | Danshenol A Mediates the Proliferation and Differentiation of Adipocytes in Thyroid-Associated Ophthalmopathy | Endocr Metab Immune Disord Drug Targets | 2026 | https://conductscience.org/library/papers/40734440 | PubMed |
| 39872310 | Novel perspectives on the pharmacological treatment of thyroid-associated ophthalmopathy. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39872310 | PubMed |
| 39721966 | Endoplasmic reticulum protein TXNDC5 modulates thyroid eye disease TGF-β1-induced myofibroblast transdifferentiation. | BMJ Open Ophthalmol | 2024 | https://conductscience.org/library/papers/39721966 | PubMed |
| 39504052 | Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts. | Invest Ophthalmol Vis Sci | 2024 | https://conductscience.org/library/papers/39504052 | PubMed |
| 39365735 | Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves' ophthalmopathy. | JCI Insight | 2024 | https://conductscience.org/library/papers/39365735 | PubMed |
| 38035032 | Current and promising therapies based on the pathogenesis of Graves' ophthalmopathy. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38035032 | PubMed |
| 37223077 | Recent studies on berberine and its biological and pharmacological activities. | EXCLI J | 2023 | https://conductscience.org/library/papers/37223077 | PubMed |
| 37176063 | Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37176063 | PubMed |
| 37108173 | Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108173 | PubMed |
| 36781592 | Traditional Chinese medicine in thyroid-associated orbitopathy. | J Endocrinol Invest | 2023 | https://conductscience.org/library/papers/36781592 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36094643
GET https://conductscience.org/api/papers/v1/36094643/references?page=2